Expression of high-risk HPV DNA and CK19 in pelvic lymph nodes in stage a-a cervical cancer and their clinical value

By              

Oncology Reports, Vol. 27, Iss. 6, 2012-01 ,pp. : 1801-1806

Spandidos Publications

Access to resources Recommend Favorite

Clinical Signficance of p53, Proliferating Cell Nuclear Antigen and bcl-2 Expression in Bladder Transitional Cell Carcinoma

By Zhu Zhaohui   Cheng Ping   Zeng Fuqing   Lu Gongcheng   Xing Shian  

The Chinese-German Journal of Clinical Oncology, Vol. 3, Iss. 1, 2004-03 ,pp. : 20-23

Springer Publishing Company

Access to resources Recommend Favorite

Prognostic Value of p53 and Proliferating Cell Nuclear Antigen Expression in Endometrial Carcinoma

By Hamel N.W.   Sebo T.J.   Wilson T.O.   Keeney G.L.   Roche P.C.   Suman V.J.   Hu T.C.   Podratz K.C.  

Gynecologic Oncology, Vol. 62, Iss. 2, 1996-08 ,pp. : 192-198

Academic Press

Access to resources Recommend Favorite

Proliferating cell nuclear antigen (PCNA): ringmaster of the genome

By Paunesku T.   Mittal S.   Protić M.   Oryhon J.   Korolev S. V.   Joachimiak A.   Woloschak G. E.  

International Journal of Radiation Biology, Vol. 77, Iss. 10, 2001-10 ,pp. : 1007-1021

Informa Healthcare

Access to resources Recommend Favorite

Expression of epithelial cell adhesion molecule and proliferating cell nuclear antigen in diethylnitrosamineinduced hepatocarcinogenesis in mice

By                

Experimental and Therapeutic Medicine, Vol. 5, Iss. 1, 2013-01 ,pp. : 138-142

Spandidos Publications

Access to resources Recommend Favorite